ReviewYonsei medical journal2011
Optimization of allergen standardization.
Review in Yonsei medical journal, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 49 citations in OpenAlex.
- Art an 3 as a candidate recombinant antigen for Artemisia pollen immunotherapy: comparative efficacy and mechanistic insights.Frontiers in medicine · 2026Article
- Enhancing production and assessing IgE reactivity of dog allergen Can f 6 in Pichia pastoris and Escherichia coli.Applied microbiology and biotechnology · 2025Article
- Neglected but Clinically Relevant Allergens in Korea.Current allergy and asthma reports · 2024Review
- Editorial: Spotlight on allergy research in Asia.Frontiers in allergy · 2024Article
- Problems Encountered Using Fungal Extracts as Test Solutions for Fungal Allergy Diagnosis.Journal of fungi (Basel, Switzerland) · 2023Review
- Investigating the microbiome of house dust mites in South Korea.Frontiers in allergy · 2023Review
- Preparation of chemically stable allergen-specific sublingual immunotherapy from Egyptian allergens.Journal of clinical laboratory analysis · 2022Article
- Quantification of Que ac 1 and Standardization of Pollen Extract from Sawtooth Oak, the Most Important Cause of Spring Pollinosis in Korea.Allergy, asthma & immunology research · 2021Article
- Novel Sensitive, Two-site ELISA for the Quantification of Der f 1 Using Monoclonal Antibodies.Allergy, asthma & immunology research · 2021Article
- Comparison of Allergenic Properties among Commercially Available House Dust Mite Allergen Extracts in Korea.Yonsei medical journal · 2021Article
- Allergens of Regional Importance in Korea.Frontiers in allergy · 2021Review
- Comparison between Newly Developed and Commercial Inhalant Skin Prick Test Reagents Using In Vivo and In Vitro Methods.Journal of Korean medical science · 2018Article
- Monoclonal Antibodies to Recombinant Fag e 3 Buckwheat Allergen and Development of a Two-site ELISA for Its Quantification.Allergy, asthma & immunology research · 2017Article
- Cross-Reactivity between Oak and Birch Pollens in Korean Tree Pollinosis.Journal of Korean medical science · 2016Article
- Standardization and Regulation of Allergen Products in the European Union.Current allergy and asthma reports · 2016Review
- Standardization of Weed Pollen Extracts, Japanese Hop and Mugwort, in Korea.Yonsei medical journal · 2016Article
- In vitro evaluation of allergen potencies of commercial house dust mite sublingual immunotherapy reagents.Allergy, asthma & immunology research · 2015Article
- Molecular approach to allergy diagnosis and therapy.Yonsei medical journal · 2014Review
- Current status of standardization of inhalant allergen extracts in Korea.Allergy, asthma & immunology research · 2014Review
- A nationwide survey of inhalant allergens sensitization and levels of indoor major allergens in Korea.Allergy, asthma & immunology research · 2014Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Preparation of high quality allergen extracts is essential for the diagnosis and immunotherapy of allergic disorders. Standardization of allergen extracts concerns determination of the allergen unit, development of reference material and measurement of the overall IgE binding capacity of an allergen extract. Recently, quantification of individual allergens has been the main focus of allergen standardization because the allergenicity of most allergen extracts is known to be mainly dependent on the content of a small number of allergen molecules. Therefore, characterization of major allergens will facilitate the standardization of allergens. In this article, we review the current state of allergen standardization. In addition, we briefly summarize the components of allergen extracts that should be under control for the optimization of allergen standardization, since its adjuvant-like activities could play an important role in allergic reactions even though the molecule itself does not bind to the IgE antibodies from subjects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.